Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world integrated TCM and Western medicine for pediatric community-acquired pneumonia
ChiCTR2200056794Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Shandong University of Traditional Chinese Medicine
- Start
- Feb 2022
- Countries
- 1
01
Overview
Phase 4, open-label trial of bazhengsan in community-acquired pneumonia (CAP) (2 arms), sponsored by Affiliated Hospital of Shandong University of Traditional Chinese Medicine. Primary endpoint: Total effective rate of disease. Started Feb 2022; status: recruiting.
02
Drugs
bazhengsan
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on ChiCTR2200056794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056794.